Project Grant R01DK137173
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Duke University a $241,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to study the regulation of metabolic diseases by the human commensal bacterium Clostridium immunis. The overarching goal is to determine the mechanism by which an exopolysaccharide (EPS) secreted by C. immunis decreases visceral adiposity, a key risk factor for type 2 diabetes and...
- Federal Project Grant Award Summary On September 8, 2025, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Inphasol Inc. $178,026 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a project titled "Phagineering the Gut Microbiome: Bacteriophages to Reduce Desulfovibrio spp. and Hydrogen Sulfide in the Intestine." The project, to be completed by August 31, 2027, develops bacteriophage-based therapeutics...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $113,688 to Harvard Medical School (President and Fellows of Harvard College) on September 13, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support fundamental biomedical research examining intestinal stem cell metabolism in the colon. The research focuses on understanding how colonic epithelial cells generate and regulate ketone bodies...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $325,522 to the University of Illinois at Chicago on September 1, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a project titled "Effects of Fructooligosacharides on Western Diet-Induced Hypothalamic Inflammation." The five-year project, concluding May 31, 2030, will conduct basic and clinical biomedical...
- The National Institute of General Medical Sciences (NIGMS) awarded a $1,338,750 Project Grant to Yale University to conduct research on how gut bacteria can influence host feeding behavior and microbiome assembly using the roundworm Caenorhabditis elegans as a model system. The project aims to develop tools and assays to study the molecular mechanisms by which gut microbes can manipulate host feeding decisions, with the goal of gaining insights that may apply to other host-microbe systems. Key...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $165,104 to Washington University in St. Louis on February 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a project grant extending through December 31, 2028. The award funds research to elucidate the mechanisms by which High-Density Lipoprotein (HDL)-mediated neutralization of lipopolysaccharide (LPS) occurs in the portal venous...
- This four-year, $924,987 project grant from the National Science Foundation's Division of Integrative Organismal Systems and Directorate for Biological Sciences will fund research into the role of extracellular RNA (exRNA) in intercellular and interkingdom communication. Specifically, the collaborative project between seven laboratories will examine the hypothesis that RNA secreted by host cells plays a key role in maintaining microbiome and overall health through cell-to-cell communication...
- Federal Grant Award Summary Harvard Medical School received a $1.66 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded August 13, 2025, with an ultimate completion date of May 31, 2030. The research project, "Identification and Biological Effects of Microbiome-Derived Sulfated Metabolites," focuses on identifying and characterizing...
- Summary The National Institute of Child Health and Human Development (NICHD) awarded a $324,000 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Texas Health Science Center at Houston, effective April 1, 2026, through August 31, 2031. The award funds research investigating the role of gut microbiota-derived butyrate in modulating inflammation and improving neurological outcomes following neonatal hypoxic-ischemic...
- Project Grant Summary The Pennsylvania State University received $113,853 in federal funding from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the project "Decoding the Polymicrobial Interactions in Bile Acid Metabolism by the Gut Microbiome." Awarded on December 12, 2025, with completion targeted for June 11, 2028, this research grant supports investigations into how multiple microbial...
IDENTIFICATION OF HUMAN GUT MICROBE-DERIVED XENOLIPIDS: IMPACT OF FIBERS AND HOST METABOLIC HEALTH - PROJECT SUMMARY: THE NEXUS BETWEEN DIET, MICROBIOME, AND HOST INVOLVES MOLECULAR SIGNALS AND XENOMETABOLITES ("NON- SELF" MOLECULES DERIVED FROM MICROBIAL METABOLISM) THAT REMAIN LARGELY UNMAPPED. DNA AND RNA SEQUENCING TECHNOLOGIES HAVE LED TO MAJOR ADVANCEMENTS IN UNDERSTANDING HOW ABUNDANCES OF SPECIFIC GUT MICROBES CORRELATE TO HEALTH, DIET, AND DISEASE; HOWEVER, THE MOST IMPORTANT INFORMATION ABOUT MICROBE-HOST AND MICROBE-MICROBE COMMUNICATION WILL EMERGE FROM GREATER UNDERSTANDING OF FUNCTIONAL OUTCOMES INCLUDING MICROBIAL XENOMETABOLISM. TO ADDRESS THIS KNOWLEDGE GAP, THE CURRENT PROPOSAL WILL LEVERAGE THE DIVERSITY OF INNOVATIVE HUMAN GUT BACTERIAL CULTURES TO EXPAND THE CATALOG OF MICROBIAL METABOLITES, WHICH CAN BE SCREENED TO CHARACTERIZE BINDING AND BIOACTIVITY CHARACTERISTICS RELEVANT TO PHYSIOLOGY AND HEALTH. THIS APPROACH IS A DIRECT RESPONSE TO GUIDANCE FROM PAR-21-253, IDENTIFICATION AND CHARACTERIZATION OF BIOACTIVE MICROBIAL METABOLITES FOR ADVANCING RESEARCH ON MICROBE-DIET-HOST INTERACTIONS. CONSIDERING THE PAUCITY OF INFORMATION RELATED TO MICROBIAL FAT METABOLITES IN PARTICULAR, OUR PRIMARY FOCUS WILL BE ON XENOLIPID DISCOVERY, INCLUDING (BUT NOT LIMITED TO) CHARACTERIZATION OF CYCLOPROPANE FATTY ACIDS (CPFAS) AS AN ILLUSTRATIVE EXAMPLE OF DISCOVERY-TO-BIOACTIVITY PROOF-OF-PRINCIPLE. FOR INSTANCE, THE EXTANT LITERATURE AND OUR PRELIMINARY RESULTS INDICATE THAT NOVEL ODD-CHAIN CPFAS ARE GENERATED BY BACTERIA HARBORING CPFA SYNTHASE (CFA), WITH CPFA CATABOLIZED BY HEPATO-SPLANCHNIC TISSUES, STORED, AND RELEASED BY WHITE ADIPOSE TISSUE. OUR DATA SUPPORT ANTI-INFLAMMATORY EFFECTS OF SOME CPFAS, AS WELL AS BINDING OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPARS). THE TEAM WILL LEVERAGE HUMAN GUT MICROBES CULTURED WITH COMBINATIONS OF FIBER/COMPLEX CARBOHYDRATE SUBSTRATES WITH OR WITHOUT DIET-RELEVANT FATS, TO DRIVE SUBSTRATE-SPECIFIC BACTERIAL COMMUNITIES AND ASSOCIATED XENOMETABOLOMES. WE WILL-FOR THE FIRST TIME-COMPREHENSIVELY IDENTIFY XENOLIPIDS AND NON-LIPID METABOLITE PATTERNS THAT TRACK THE FIBER AND FATTY ACID MILIEU, AND THAT CORRELATE WITH SPECIFIC BACTERIAL COMMUNITIES VARYING IN PHYLOGENY. THIS WILL EXPAND THE LIBRARY OF MICROBE METABOLITES AND SHED LIGHT ON HOW DIETARY COMPONENTS SUCH AS FIBERS AND LIPIDS INTERACT TO ALTER THE XENOMETABOLOME. A COMPLEMENTARY AIM TO INTERROGATE THE EFFECTS OF XENOLIPIDS ON NUCLEAR RECEPTORS, INFLAMMATION AND GPCR READ-OUTS, AND BROADER EFFECTS IN GUT ORGANOIDS WILL LINK OUR FINDINGS TO POTENTIAL BIOACTIVITIES, ONE OF THE REMITS OF PAR-21-253.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $687.6k | 4/3/26 | ||
| Not listed | $687.9k | 5/1/25 | ||
| Not listed | $686.7k | 6/12/24 | ||
| Not listed | $686.7k | 6/12/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
A240376S001S | Purdue University | Project Grant R01DK137173 | $458.0k | 7/30/25 |